David Morris, MD, FACS, shares advice on followup with patients on androgen deprivation therapy for prostate cancer.
January 2023 AbbVie Inc. Company Confidential
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.